These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 2534687)

  • 1. The binding characteristics of 3H-terguride in various brain areas.
    Dobrovský K; Valchár M; Dlabac A
    Act Nerv Super (Praha); 1989 Dec; 31(4):274-5. PubMed ID: 2534687
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparison of (3H)-terguride and (3H)-spiperone binding to dopamine receptors in the rat striatum.
    Valchár M; Dobrovský K; Krejcí I; Dlabac A
    Act Nerv Super (Praha); 1989 Apr; 31(1):77-9. PubMed ID: 2675526
    [No Abstract]   [Full Text] [Related]  

  • 3. Binding characteristics of the dopamine agonist/antagonist [3H]terguride (transdihydrolisuride) in the rat striatum.
    Valchár M; Vrsecká M; Krejcí I; Dlabac A
    Eur J Pharmacol; 1987 Apr; 136(1):97-101. PubMed ID: 3297739
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [76Br]bromolisuride: a new tool for quantitative in vivo imaging of D-2 dopamine receptors.
    Maziere B; Loc'h C; Stulzaft O; Hantraye P; Ottaviani M; Comar D; Maziere M
    Eur J Pharmacol; 1986 Aug; 127(3):239-47. PubMed ID: 2944753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of GTP and sodium on rat striatal dopamine receptors labeled with lisuride.
    Uzumaki H; Govoni S; Memo M; Carruba MO; Trabucchi M; Spano PF
    Brain Res; 1982 Sep; 248(1):185-7. PubMed ID: 7127137
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Binding of [3H]pergolide mesylate to dopamine receptors of mammalian brains.
    Wong DT; Bymaster FP; Lane PT; Kau D; Bach NJ; Kornfeld EC
    Res Commun Chem Pathol Pharmacol; 1980 Nov; 30(2):195-210. PubMed ID: 7444158
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [3H]quinpirole binding to putative D2 and D3 dopamine receptors in rat brain and pituitary gland: a quantitative autoradiographic study.
    Levant B; Grigoriadis DE; DeSouza EB
    J Pharmacol Exp Ther; 1993 Feb; 264(2):991-1001. PubMed ID: 8437136
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effects of terguride, an ergot alkaloid derivative, on the central nervous system: biochemical and behavioral studies].
    Ikoma Y; Akai T; Nakata Y; Hara K; Wachtel H; Yamaguchi M
    Nihon Yakurigaku Zasshi; 1993 Aug; 102(2):113-29. PubMed ID: 8370555
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Binding of antiparkinsonian ergot derivatives to the dopamine receptor.
    Weir RL; Hruska RE; Silbergeld EK
    Psychopharmacology (Berl); 1981; 75(2):119-23. PubMed ID: 6798600
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discriminative stimulus properties of lisuride revisited: involvement of dopamine D2 receptors.
    Cunningham KA; Callahan PM; Appel JB
    J Pharmacol Exp Ther; 1987 Apr; 241(1):147-51. PubMed ID: 3553537
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Agents to improve cerebrovascular circulation and cerebral metabolism--lisuride].
    Yamaguchi T
    Nihon Rinsho; 1985 Feb; 43(2):397-401. PubMed ID: 3889414
    [No Abstract]   [Full Text] [Related]  

  • 12. The interaction of lisuride, an ergot derivative, with serotonergic and dopaminergic receptors in rabbit brain.
    Rosenfeld MR; Makman MH
    J Pharmacol Exp Ther; 1981 Mar; 216(3):526-31. PubMed ID: 7205633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [3H]-quinelorane binds to D2 and D3 dopamine receptors in the rat brain.
    Gackenheimer SL; Schaus JM; Gehlert DR
    J Pharmacol Exp Ther; 1995 Sep; 274(3):1558-65. PubMed ID: 7562534
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Binding of 3H-lisuride hydrogen maleate to striatal membranes of rat brain.
    Fujita N; Saito K; Yonehara N; Watanabe Y; Yoshida H
    Life Sci; 1979 Sep; 25(11):969-73. PubMed ID: 513944
    [No Abstract]   [Full Text] [Related]  

  • 15. Pharmacokinetics of oral terguride in patients with a prolactinoma.
    Lapka R; Marek J; Rejholec V; Franc Z
    Eur J Clin Pharmacol; 1986; 30(3):363-5. PubMed ID: 3732377
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of GYKI-32 887 on dopamine (D2) and serotonin (5-HT1 and 5-HT2) receptors.
    Berzétei IP; Bagdy E; Hardy M; Borsy J
    Pol J Pharmacol Pharm; 1985; 37(3):237-42. PubMed ID: 4070077
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Direct binding of 3H-lisuride to adrenergic and serotonergic receptors.
    Battaglia G; Titeler M
    Life Sci; 1981 Aug; 29(9):909-16. PubMed ID: 7300582
    [No Abstract]   [Full Text] [Related]  

  • 18. Evaluation of terguride in patients with Parkinson's disease.
    Suchy I; Rinne UK; Wachtel H
    Adv Neurol; 1987; 45():577-81. PubMed ID: 3548267
    [No Abstract]   [Full Text] [Related]  

  • 19. In vitro characterization of SLV308 (7-[4-methyl-1-piperazinyl]-2(3H)-benzoxazolone, monohydrochloride): a novel partial dopamine D2 and D3 receptor agonist and serotonin 5-HT1A receptor agonist.
    Glennon JC; Van Scharrenburg G; Ronken E; Hesselink MB; Reinders JH; Van Der Neut M; Long SK; Feenstra RW; McCreary AC
    Synapse; 2006 Dec; 60(8):599-608. PubMed ID: 17001660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of a partial D2-like receptor agonist on striatal dopamine autoreceptor functioning in preweanling rats.
    Yoshida ST; Baella SA; Stuebner NM; Crawford CA; McDougall SA
    Brain Res; 2006 Feb; 1073-1074():269-75. PubMed ID: 16427034
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.